样式: 排序: IF: - GO 导出 标记为已读
-
Randomised clinical trial: First‐line infliximab biosimilar is cost‐effective compared to conventional treatment in paediatric Crohn's disease Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-22 Stephanie A. Vuijk, Maria M. E. Jongsma, Britt M. Hoeven, Maarten A. Cozijnsen, Merel van Pieterson, Tim G. J. de Meij, Obbe F. Norbruis, Michael Groeneweg, Victorien M. Wolters, Herbert van Wering, Thalia Hummel, Janneke Stapelbroek, Cathelijne van der Feen, Patrick F. van Rheenen, Michiel P. van Wijk, Sarah Teklenburg, Dimitris Rizopoulos, Marten J. Poley, Johanna C. Escher, Lissy de Ridder
SummaryBackgroundData on cost‐effectiveness of first‐line infliximab in paediatric patients with Crohn's disease are limited. Since biologics are increasingly prescribed and accompanied by high costs, this knowledge gap needs to be addressed.AimTo investigate the cost‐effectiveness of first‐line infliximab compared to conventional treatment in children with moderate‐to‐severe Crohn's disease.MethodsWe
-
Editorial: Mortality in immune‐mediated inflammatory diseases during early adulthood Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-21 Paul Henderson
-
Editorial: Foretelling the future—Emerging role of magnetic resonance enterography as a prognostic tool in Crohn's disease Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-21 Siri A. Urquhart, Joel G. Fletcher, David H. Bruining
-
Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-21 Enrico N. De Toni, Julia Mayerle, Bettina Oehrle, Max Seidensticker, Lorenza Rimassa, Alexander Philipp, Daniel Roessler, Najib Ben Khaled
-
Editorial: High qHBsAg—is it a good or bad signal? Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-21 Beom Kyung Kim
-
Editorial: Peering through the fog—New tools to assess neurocognitive symptoms in coeliac disease Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-21 Javier A. Villafuerte Gálvez, Daniel A. Leffler
-
Editorial: Enriching our understanding of MASLD through representation of under‐reported populations Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-21 Niharika Samala, Eduardo Vilar‐Gomez
-
Letter: Risks of proton pump inhibitor treatment in cirrhotic patients Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-21 Jiamei Wang, Feng Wen, Jian Zhao
-
Letter: The enigma of angiotensin receptor blocker‐associated enteropathy Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-21 Mustafa Mohamedrashed, Leya Nedumannil, Mayur Garg
-
Editorial: Exploring the influence of diet on later‐onset ulcerative colitis—Are eggs and spicy foods the key factors in Asia? Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-21 Shinji Okabayashi, Taku Kobayashi
-
Editorial: Redefining liver health—Personalised approach to assessment of serum ALT in clinical practice Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-21 Basile Njei, Joseph K. Lim
-
Editorial: Can dietary gluten restriction improve hepatic steatosis? Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-21 Hariklia Kranidioti, Melanie Deutsch
-
Letter: Association of persistently high HBsAg levels during HBeAg‐seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-21 Jian Wang, Yifan Pan, Ye Xiong, Chao Wu, Rui Huang
-
Editorial: Are changes in quantitative biliary metrics the first sign of progression in primary sclerosing cholangitis? Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-21 John E. Eaton, Sudhakar K. Venkatesh
-
Diagnostic yield from symptomatic lower gastrointestinal endoscopy in the UK: A British Society of Gastroenterology analysis using data from the National Endoscopy Database Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-18 David Beaton, Linda Sharp, Liya Lu, Nigel Trudgill, Mo Thoufeeq, Brian Nicholson, Peter Rogers, James Docherty, Anna Jenkins, A. John Morris, Thomas Rösch, Matthew Rutter
SummaryBackgroundThe value of lower gastrointestinal endoscopy (LGIE; colonoscopy or sigmoidoscopy) relates to its ability to detect clinically relevant findings, predominantly cancers, preneoplastic polyps or inflammatory bowel disease. There are concerns that many LGIEs are performed on low‐risk patients with limited benefit.AimsTo determine the diagnostic outcomes of LGIE for common symptoms.MethodsWe
-
Prospective evaluation of patients with non‐cirrhotic portal hypertension: A single centre study Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-17 Maria Mironova, Harish Gopalakrishna, Gracia Maria Viana Rodriguez, Nehna Abdul Majeed, Asif A. Hitawala, Ivan J. Fuss, Jenna R. E. Bergerson, Alison J. Faust, Jacqueline M. Laurin, Jaha Norman‐Wheeler, Shani Scott, Julian Hercun, Bernadette Redd, David E. Kleiner, Christopher Koh, Theo Heller
SummaryBackgroundNon‐cirrhotic portal hypertension (NCPH) is a spectrum of liver diseases, including porto‐sinusoidal vascular disorder, with portal hypertension (PH) in the absence of cirrhosis. The natural history and diagnostic approach to NCPH are not well understood.AimWe aimed to evaluate disease progression and outcomes in NCPH.MethodsPatients with or at risk for NCPH were enrolled in a single
-
Application of clinical decision support tools for predicting outcomes with vedolizumab therapy in patients with inflammatory bowel disease: A KASID multicentre study Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-14 Kyuwon Kim, Jae Jun Park, Hyuk Yoon, Jun Lee, Kyeong Ok Kim, Eun Sun Kim, Su Young Kim, Sun-Jin Boo, Yunho Jung, Jun Hwan Yoo, Sung Wook Hwang, Sang Hyoung Park, Suk-Kyun Yang, Byong Duk Ye
-
Crohn's disease after surgery: Changes in post‐operative management strategies over time and their impact on long‐term re‐operation rate—A retrospective multicentre real‐world study Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-15 Annalisa Aratari, Maria Lia Scribano, Daniela Pugliese, Valentina Baccolini, Fabiola De Biasio, Serena Verna, Chiara Morretta, Stefano Festa, Alessandro Armuzzi, Claudio Papi
-
Paediatric‐onset immune‐mediated inflammatory disease is associated with an increased mortality risk—A nationwide study Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-10 Mikkel Malham, Sabine Jansson, Helene Ingels, Marianne Hørby Jørgensen, Naja Hulvej Rod, Vibeke Wewer, Matthew P. Fox
-
-
Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-09 Arta Aliu, Daan H. C. A. Bosch, Daniel Keszthelyi, Ashkan Rezazadeh Ardabili, Jean‐Frederic Colombel, Rachel Sawyer, Hans Törnblom, Ailsa Hart, Daisy M. A. E. Jonkers, Marieke J. Pierik, Zlatan Mujagic
-
Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-09 Matthew J. Townsend, Isaac J. Benque, Michael Li, Shilpa Grover
-
Editorial: Recompensation in PBC is good. But is it good enough? Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-09 Xavier Verhelst
LINKED CONTENTThis article is linked to Hofer et al papers. To view these articles, visit https://doi.org/10.1111/apt.17908 and https://doi.org/10.1111/apt.17966
-
Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-09 Benedikt Silvester Hofer, Lukas Burghart, Emina Halilbasic, Benedikt Simbrunner, Oleksandr Petrenko, Mattias Mandorfer, Albert Friedrich Stättermayer, Michael Trauner, Thomas Reiberger
LINKED CONTENTThis article is linked to Hofer et al papers. To view these articles, visit https://doi.org/10.1111/apt.17908 and https://doi.org/10.1111/apt.17924
-
Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms–still a long way to go… Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-09 Sabine Roman, François Mion
LINKED CONTENTThis article is linked to Calabrese et al papers. To view these articles, visit https://doi.org/10.1111/apt.17934 and https://doi.org/10.1111/apt.17960
-
Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms—still a long way to go… Authors' reply' Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-09 Francesco Calabrese, Andrea Pasta, Giorgia Bodini, Manuele Furnari, Patrizia Zentilin, Edoardo G. Giannini, Daria Maniero, Domenico Della Casa, Giovanni Cataudella, Marzio Frazzoni, Roberto Penagini, Arsiè Elena, Nicola De Bortoli, Pierfrancesco Visaggi, Vincenzo Savarino, Edoardo Savarino, Elisa Marabotto
LINKED CONTENTThis article is linked to Calabrese et al papers. To view these articles, visit https://doi.org/10.1111/apt.17934 and https://doi.org/10.1111/apt.17955
-
Editorial: Time to address quality of life in our IBD treatment—IBD nurse intervention as a key part of multimodal IBD management Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-09 Jakob B. Seidelin
LINKED CONTENTThis article is linked to Bokemeyer et al paper. To view this article, visit https://doi.org/10.1111/apt.17926
-
Letter: Diet‐microbiome interactions in inflammatory bowel disease—Navigating towards individualised dietary strategies Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-09 Iris Barth, Corien L. Stevens, Colette J. Strokap, Marjo J. E. Campmans‐Kuijpers, Arno R. Bourgonje, Gerard Dijkstra
LINKED CONTENTThis article is linked to Faqerah et al paper. To view this article, visit https://doi.org/10.1111/apt.17720
-
Letter: Determining optimal ALT cut‐off values for predicting significant hepatic histological changes in chronic hepatitis B virus infection Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-09 Jianrong Li, Dalong Yang, Jianhong Zhong, Yingyang Liao
LINKED CONTENTThis article is linked to Kang et al paper. To view this article, visit https://doi.org/10.1111/apt.17862
-
Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-09 Jian Wang, Shaoqiu Zhang, Zhiyi Zhang, Chao Wu, Rui Huang
LINKED CONTENTThis article is linked to Sandmann et al papers. To view these articles, visit https://doi.org/10.1111/apt.17878 and https://doi.org/10.1111/apt.17962
-
Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D—Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-09 Lisa Sandmann, Heiner Wedemeyer, Katja Deterding
LINKED CONTENTThis article is linked to Sandmann et al papers. To view these articles, visit https://doi.org/10.1111/apt.17878 and https://doi.org/10.1111/apt.17923
-
Letter: The emerging role of novel capsule endoscopy systems in gastroenterology with specific reference to small bowel Crohn's disease Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-09 Leya Nedumannil, Mustafa Mohamedrashed, Anuj Bohra, Siddharth Sood, Diana Lewis
LINKED CONTENTThis article is linked to Thwaites et al papers. To view these articles, visit https://doi.org/10.1111/apt.17944 and https://doi.org/10.1111/apt.17970
-
Letter: The emerging role of novel capsule endoscopy systems in gastroenterology with specific reference to small bowel Crohn's disease. Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-09 Phoebe A. Thwaites, Peter R. Gibson
LINKED CONTENTThis article is linked to Thwaites et al papers. To view these articles, visit https://doi.org/10.1111/apt.17944 and https://doi.org/10.1111/apt.17946
-
A prospective study on the prevalence of at‐risk MASH in patients with type 2 diabetes mellitus in the United States Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-08 Nikita Mittal, Harris Siddiqi, Egbert Madamba, Lisa Richards, Ricki Bettencourt, Veeral Ajmera, Rohit Loomba
-
Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction‐associated steatotic liver disease Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-04 Nabil Noureddin, Daniel Q. Huang, Ricki Bettencourt, Harris Siddiqi, Abdul M. Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idilman, Mesut Gumussoy, Digdem Kuru Oz, Ayse Erden, Tolga Gidener, Alina M. Allen, Veeral Ajmera, Rohit Loomba
-
Quantitative MRCP and metrics of bile duct disease over time in patients with primary sclerosing cholangitis: A prospective study Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-04 Palak J. Trivedi, Katherine Arndtz, Nadir Abbas, Alison Telford, Liam Young, Rajarshi Banerjee, Peter Eddowes, Kartik S. Jhaveri, Gideon M. Hirschfield
SummaryBackgroundImaging markers of biliary disease in primary sclerosing cholangitis (PSC) have potential for use in clinical and trial disease monitoring. Herein, we evaluate how quantitative magnetic resonance cholangiopancreatography (MRCP) metrics change over time, as per the natural history of disease.MethodsIndividuals with PSC were prospectively scanned using non‐contrast MRCP. Quantitative
-
Review article: Telecare in gastroenterology—Within the COVID‐19 pandemic and beyond Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-04-01 Fatima Hakak, Rajan N. Patel, Richard B. Gearry
-
Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease cirrhosis and type 2 diabetes Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-27 Mohamed I. Elsaid, Na Li, Stephen A. Firkins, Vinod K. Rustgi, Electra D. Paskett, Chathur Acharya, K. Rajender Reddy, Chien Wei Chiang, Khalid Mumtaz
-
Systematic scoping review: Use of the faecal immunochemical test residual buffer to enhance colorectal cancer screening Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-27 Timothy McAuliffe, Joseph C. Anderson, Robin J. Larson, Douglas J. Robertson
-
The epidemiology and management of Clostridioides difficile infection—A clinical update Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-27 Lindsay M. Clarke, Jessica R. Allegretti
-
Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-25 Jian Wang, Tao Fan, Shaoqiu Zhang, Chao Wu, Rui Huang
LINKED CONTENTThis article is linked to Hong et al papers. To view these articles, visit https://doi.org/10.1111/apt.17819 and https://doi.org/10.1111/apt.17937
-
Letter: Thioguanine, an underutilised option in inflammatory bowel disease? Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-25 John D. Chetwood, Sudarshan Paramsothy, Rupert W. Leong
LINKED CONTENTThis article is linked to Vasudevan et al papers. To view these articles, visit https://doi.org/10.1111/apt.17831 and https://doi.org/10.1111/apt.17957
-
Editorial: Muscles at the expense of liver injury. Is it worth it? Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-25 C. Stephens
LINKED CONTENTThis article is linked to Nash et al paper. To view this article, visit https://doi.org/10.1111/apt.17906
-
Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B—Author's reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-25 Hyeyeon Hong, Jonggi Choi
LINKED CONTENTThis article is linked to Hong et al papers. To view these articles, visit https://doi.org/10.1111/apt.17819 and https://doi.org/10.1111/apt.17922
-
Letter: Modifying the Mayo endoscopic subscore for improved prognostic insights. Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-25 Matthias Lenfant, Bram Verstockt, João Sabino, Séverine Vermeire, Marc Ferrante
LINKED CONTENTThis article is linked to Lenfant et al papers. To view these articles, visit https://doi.org/10.1111/apt.17753 and https://doi.org/10.1111/apt.17912
-
Letter: Modifying the Mayo endoscopic subscore for improved prognostic insights Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-25 Kunio Asonuma, Shintaro Sagami, Taku Kobayashi
LINKED CONTENTThis article is linked to Lenfant et al papers. To view these articles, visit https://doi.org/10.1111/apt.17753 and https://doi.org/10.1111/apt.17935
-
Letter: Thioguanine, an under‐utilised option in inflammatory bowel disease? Authors' reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-25 Abhinav Vasudevan, Danny Con, Daniel R. van Langenberg
LINKED CONTENTThis article is linked to Vasudevan et al papers. To view these articles, visit https://doi.org/10.1111/apt.17831 and https://doi.org/10.1111/apt.17920
-
-
Review article: Recent advances in ascites and acute kidney injury management in cirrhosis Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-25 Danielle Adebayo, Florence Wong
-
Review article: Upper gastrointestinal bleeding – review of current evidence and implications for management Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-22 Dennis L. Shung, Loren Laine
-
Review article: New developments in biomarkers and clinical drug development in alpha‐1 antitrypsin deficiency‐related liver disease Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-22 Rohit Loomba, Ginger Clark, Jeff Teckman, Veeral Ajmera, Cynthia Behling, Mark Brantly, David Brenner, Jeanine D'Armiento, Michael W. Fried, Janani S. Iyer, Mattias Mandorfer, Don C. Rockey, Monica Tincopa, Raj Vuppalanchi, Zobair Younossi, Aleksander Krag, Alice M. Turner, Pavel Strnad
-
Featured Cover Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-20 Xiao Cheng, Yujun Tang, Qinjun He, Jiankang Song, Kunyuan Wang, Hui Li, Jing Huang, Weibin Wang, Junying Li, Haiyu Wang, Minghan Tu, Jinzhang Chen, Guosheng Yuan, Shuai Kang, Hongyan Liu, Xiaoyong Zhang, Wenfan Luo, Yali Ji, Xiaoqin Lan, Ling Zhou, Qintao Lai, Xiaoqin Luo, Qiaoping Wu, Damei Zhou, Yingqi Tan, Jinjun Chen, Xiaofeng Zhang
-
Prevalence of at‐risk MASH, MetALD and alcohol‐associated steatotic liver disease in the general population Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-19 Carolin V. Schneider, Kai Markus Schneider, Anastasia Raptis, Helen Huang, Christian Trautwein, Rohit Loomba
-
Skeletal muscle mass increases after viral eradication with direct‐acting antivirals in patients with chronic hepatitis C: A longitudinal study Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-19 Marta Paula Pereira Coelho, Thais Pontello de Vries, Aline Marcos Pires, Milena Pereira Parreira, Érika Ramos de Alvarenga, Rodrigo Dias Cambraia, Rodrigo Ribeiro dos Santos, Juliana Maria Trindade Bezerra, Enrico Antonio Colosimo, Gifone Aguiar Rocha, Luciana Diniz Silva
-
Efficacy and safety of filgotinib for ulcerative colitis: A real‐world multicenter retrospective study in Japan Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-18 Shintaro Akiyama, Kaoru Yokoyama, Soichi Yagi, Shinichiro Shinzaki, Kozo Tsuruta, Shinichiro Yoshioka, Minako Sako, Hiromichi Shimizu, Mariko Kobayashi, Toshiyuki Sakurai, Kei Nomura, Tomoyoshi Shibuya, Masahiro Takahara, Sakiko Hiraoka, Kyohei Sugai, Shunichi Yanai, Atsushi Yoshida, Miki Koroku, Teppei Omori, Masayuki Saruta, Takayuki Matsumoto, Ryuichi Okamoto, Kiichiro Tsuchiya, Toshimitsu Fujii
SummaryBackground and AimsWhile filgotinib, an oral Janus kinase (JAK) 1 preferential inhibitor, is approved for moderately to severely active ulcerative colitis (UC), real‐world studies assessing its short‐ and long‐term efficacy and safety are limited.MethodsThis is a multicenter, retrospective study of UC patients who started filgotinib between March 2022 and September 2023. The primary outcome
-
Meta-analysis: Incidence of cirrhosis and hepatocellular carcinoma in patients with Fontan palliation Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-18 Asif A. Hitawala, Harish Gopalakrishna, Maria Mironova, Alicia A. Livinski, Elizabeth C. Wright, Tacy Downing, Seiji Ito, Stacy D. Fisher, Ari M. Cedars, Anitha S. John, Theo Heller
-
Poor accuracy and sustainability of the first‐step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-18 Antonio De Vincentis, Federica Tavaglione, Shinichi Namba, Masahiro Kanai, Yukinori Okada, Yoichiro Kamatani, Samantha Maurotti, Claudio Pedone, Raffaele Antonelli Incalzi, Luca Valenti, Stefano Romeo, Umberto Vespasiani‐Gentilucci
-
Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-14 Nina Dominik, Bernhard Scheiner, Alberto Zanetto, Lorenz Balcar, Georg Semmler, Elena Campello, Michael Schwarz, Rafael Paternostro, Benedikt Simbrunner, Benedikt S. Hofer, Albert Friedrich Stättermayer, Matthias Pinter, Michael Trauner, Peter Quehenberger, Paolo Simioni, Thomas Reiberger, Mattias Mandorfer
-
Editorial: Shorter course of intravenous terlipressin in acute variceal bleeding—the promise, controversies and future directions. Author's reply Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-10 Sagnik Biswas, Manas Vaishnav, Shalimar
This article is linked to Vaishnav et al papers. To view these articles, visit https://doi.org/10.1111/apt.17868 and https://doi.org/10.1111/apt.17882
-
Review article: Current indications and selection criteria for early liver transplantation in severe alcohol-associated hepatitis Aliment. Pharm. Ther. (IF 7.6) Pub Date : 2024-03-12 Carolina Ramirez-Cadiz, Hanna Blaney, Natalia Kubanek, Luis Antonio Díaz, Rohit Loomba, Lubomir Skladany, Juan Pablo Arab